Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06994494 · ClinicalTrials.gov registry record

Noninvasive Continuous BP Monitoring in Newborns Based on Pulsatile Signal Morphological Features Using NIRS

A clinical trial of Hypotension and Unstable Blood Pressure, sponsored by Massachusetts General Hospital.

Recruiting
Registry status
80
Enrollment target
2
Study locations

NCT06994494: Recruiting study of Hypotension and Unstable Blood Pressure, sponsored by Massachusetts General Hospital.

NCT06994494 is a study of Hypotension and Unstable Blood Pressure that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 80 participants, roughly in line with the 74-participant average among 12 other Hypotension trials with a reported enrollment target. The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06994494, a study of Hypotension and Unstable Blood Pressure, is actively recruiting participants, sponsored by Massachusetts General Hospital.

RECRUITING
Registry status
80 participants
Enrollment target
2
Study locations

Study Summary

The goal of this study is to evaluate if a novel near-infrared spectroscopy (NIRS) device can accurately estimate blood pressure in newborns at risk for unstable blood pressure. The main questions it aims to answer are: * Can NIRS accurately estimate blood pressure when compared to the gold standard, arterial line blood pressure * Can NIRS accurately estimate blood pressure when compared to infants with cuff blood pressure monitoring Researchers will compare NIRS-based estimates to arterial line blood pressure readings and manual cuff measurements to optimize and validate the FlexNIRS device for neonates to accurately estimate blood pressure continuously and noninvasively. Participants will wear a small, noninvasive NIRS sensor on the forehead.

Primary Outcome

Determine the correlation between FlexNIRS based blood pressure estimation and invasive A-line blood pressure as the gold standard or periodic BP cuff readings performed by clinical staff.

Study Locations (2)

Massachusetts

  • Massachusettes General Hospital - Boston
  • Brigham and Women's Hospital - Boston

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2025-04-09
Est. Completion 2026-11-30
Massachusetts General Hospital

2,032 total trials

What NCT06994494 shows while recruiting

NCT06994494 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 80 participants, a relatively small participant target, roughly in line with the 74-participant average among 12 other Hypotension trials with a reported enrollment target.

The record links to 2 conditions, with Hypotension appearing as the primary indexed condition, and to 0 interventions.

NCT06994494 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06994494 about?

NCT06994494 is a clinical study titled "Noninvasive Continuous BP Monitoring in Newborns Based on Pulsatile Signal Morphological Features Using NIRS". The goal of this study is to evaluate if a novel near-infrared spectroscopy (NIRS) device can accurately estimate blood pressure in newborns at risk for unstable blood pressure. The main questions it aims to answer are: * Can NIRS accurately estimate blood pressure when compared to the gold standar...

What is the current status of trial NCT06994494?

This trial is currently recruiting. The enrollment target is 80 participants. The study started on 2025-04-09. Estimated completion is 2026-11-30.

What conditions does trial NCT06994494 study?

This clinical trial studies the following conditions: Hypotension, Unstable Blood Pressure.

Who is sponsoring clinical trial NCT06994494?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06994494 being conducted?

This trial has 2 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypotension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06994494's enrollment target sits among peer trials

80 5th of 12 higher than 8 of 12 other Hypotension trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hypotension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

  • NCT01659203 · 80 participants · Phase 1

    Proton or Photon RT for Retroperitoneal Sarcomas

  • NCT01803451 · 80 participants · Early Phase 1

    Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass

  • NCT01964859 · 80 participants · Phase 2

    Feasibility Study for Fibroblast Autologous Skin Grafts

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06994494, the US trial registry maintained by the National Library of Medicine. NCT06994494 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.